Advertisement

Production and Regulation of Human T Lymphocyte Chemotactic Factor (LCF)

  • D. E. Van Epps
  • J. Potter
  • S. L. Brown
Part of the Satellite Symposia of the IUPHAR 9th International Congress of Pharmacology book series (SSNIC)

Abstract

The mobilisation of leukocytes to inflammatory sites is crucial to host defense. Over the years a wealth of information has evolved concerning the mechanism of leukocyte locomotion and factors with the potential specifically to attract these cells to inflammatory foci in vivo. The majority of research in this area has centred on the chemotactic response of neutrophils (PMN) and to a lesser extent on the response of monocytes and macrophages. Various naturally occurring and synthetic chemotactic factors for PMNs and monocytes have been described and they include complement fragments such as C5a (1), products of arachidonic acid metabolism such as leukotriene B4 (2), as well as other cell-derived lipids, such as acetyl glyceryl ether phosphorylcholine (platelet activating factor) (3). More recently, the neurohormones, beta-endorphin, met-enkephalin (4), and substance P (5), have been shown to stimulate mononuclear cell chemotaxis. In many cases, specific receptors for these various chemotactic factors have been defined on both PMNs and monocytes (6–10). In spite of this vast array of information on the mechanism of neutrophil and monocyte locomotion, very little is known about lymphocyte chemotaxis and the agents that are responsible for attracting these cells to sites of antigenic challenge in vivo.

Keywords

Tetanus Toxoid Mixed Lymphocyte Reaction Migration Index Lymphocyte Migration Human Mononuclear Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Fernandez, H.N., Henson, P.M., Otani, A. and Hugli, T.E. (1978). Chemotactic response to human C3a and C5a anaphylatoxins. J. Immunol., 120, 109–115.Google Scholar
  2. 2.
    Ford-Hutchinson, A.W., Bray, M.A., Doig, M.V., Shipley, M.E. and Smith, M.J.H. (1980). Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature, 286, 264–265.CrossRefGoogle Scholar
  3. 3.
    Shaw, J.O., Pinckard, N., Ferrigni, K.S., McManus, L.M. and Hanahan, D.J. (1981). Activation of human neutrophils with 1–0-hexadecyl/octadecyl-2-acetyl-Sn-glyceryl-3-phosphorylcholine (platelet activating factor). J. Immunol., 127, 1250–1255.Google Scholar
  4. 4.
    Van Epps, D.E. and Saland, L. (1984). Beta-endorphin and metenkephalin stimulate human peripheral blood mononuclear cell chemotaxis. J. Immunol., 132, 3046–3053.Google Scholar
  5. 5.
    Marasco, W.A., Showell, H.J. and Becker, E.L. (1981). Substance P binds to the formylpeptide chemotaxis receptor on the rabbit neutrophil. Biochem. Biophys. Res. Commun., 99, 1065–1072.Google Scholar
  6. 6.
    Chenoweth, D.E. and Hugli, T.E. (1978). Demonstration of specific C5a receptor on intact human polymorphonuclear leukocytes. Proc. Natl. Acad. Sci. USA, 75, 3943–3947.CrossRefGoogle Scholar
  7. 7.
    Weinberg, J.B., Muscato, J.J. and Niedel, J.E. (1981). Monocyte chemotactic peptide receptor: Functional characteristics and ligand-induced regulation. J. Clin. Invest., 68, 621–630.CrossRefGoogle Scholar
  8. 8.
    Williams, L.T., Snyderman, R., Pike, M.C. and Lefkowitz, R.J. (1977). Specific receptor sites for chemotactic peptides on human polymorphonuclear leukocytes. Proc. Natl. Acad. Sci. USA, 74, 1204–1208.CrossRefGoogle Scholar
  9. 9.
    Van Epps, D.E. and Chenoweth, D.E. (1984). Analysis of the binding of fluorescent C5a and C3a to human peripheral blood leukocytes. J. Immunol., 132, 2862–2867.Google Scholar
  10. 10.
    Goldman, D.W. and Goetzl, E.J. (1984). Heterogeneity of human polymorphonuclear leukocyte receptors for leukotriene B4: Identification of a subset of high affinity receptors that transduce the chemotactic response. J. Exp. Med., 159, 1027–1041.Google Scholar
  11. 11.
    Russell, R.J., Wilkinson, P.C., Sless, F. and Parrott, D.M.C. (1975). Chemotaxis of lymphoblasts. Nature, 256, 646–648.CrossRefGoogle Scholar
  12. 12.
    El-Naggar, A.K., Van Epps, D.E. and Williams, R.C. Jr. (1980). Human B and T lymphocyte locomotion in response to casein, C5a and f-Met-Leu-Phe. Cell Immunol., 56, 365–373.CrossRefGoogle Scholar
  13. 13.
    El-Naggar, A.K., Van Epps, D.E. and Williams, R.C. Jr. (1981). Effect of culturing on the human lymphocyte locomotion response to casein, C5a and f-Met-Leu-Phe. Cell Immunol., 60, 43–49.CrossRefGoogle Scholar
  14. 14.
    Parrott, D.M.V., Good, R.A., O’Neill, G.J. and Gupta, S. (1978). Heterogeneity of locomotion in human T-cell subsets. Proc. Natl. Acad. Sci. USA, 75, 2392–2395.CrossRefGoogle Scholar
  15. 15.
    McCarty, J. and Goetzl, E.J. (1979). Stimulation of human T-lymphocyte chemokinesis by arachidonic acid. Cell Immunol., 43, 103–112.CrossRefGoogle Scholar
  16. 16.
    Payan, D.G. and Goetzl, E.J. (1981). The dependence of human T-lymphocyte migration on the 5-lipoxygenation of endogenous arachidonic acid. J. Clin. Immunol., 1., 266–270.Google Scholar
  17. 17.
    Wilkinson, P.C., Parrott, D.M.V., Russell, R.J. and Sless, F. (1977). Antigen-induced locomotor responses in lymphocytes . J. Exp. Med., 145, 1158–1168.Google Scholar
  18. 18.
    Van Epps, D.E., Potter, J.W. and Durant, D.A. (1983). Production of a human T-lymphocyte chemotactic factor by T-cell subpopulations. J. Immunol., 130, 2727–2731.Google Scholar
  19. 19.
    Van Epps, D.E., Durant, D.A. and Potter, J.W. (1983). Migration of human helper/inducer T cells in response to supernatants from Con A-stimulated suppressor/cytotoxic T cells. J. Immunol., 131, 697–700.Google Scholar
  20. 20.
    Center, D.M. and Cruikshank, W. (1982). Modulation of lymphocyte migration by human lymphokines. I. Identification and characterization of chemoattractant activity for lymphocytes from mitogen-stimulated mononuclear cells. J. Immunol., 126, 2563–2568.Google Scholar
  21. 21.
    Cruikshank, W. and Center, D.M. (1982). Modulation of lymphocyte migration by human lymphokines. II. Purification of a lymphotactic factor (LCF). J. Immunol., 128, 2569–2574.Google Scholar
  22. 22.
    El Naggar, A., Van Epps, D.E. and Williams, R.C. Jr. (1982). A human lymphocyte chemotactic factor produced by the mixed lymphocyte reaction. J. Lab. Clin. Med., 100, 558–565.Google Scholar
  23. 23.
    Ward, P.A., Unanue, E.R., Goralnick, S.J. and Schreiner, G.F. (1977). Chemotaxis of rat lymphocytes. J. Immunol., 119, 416–421.Google Scholar
  24. 24.
    Shimokawa, Y., Miura, K., Hifumi, M. and Hayashi, H. (1983). Lymphocyte chemotaxis in inflammation. VI. Lyt phenotype analysis of effector cells responsible for producing murine lymphocyte chemotactic factor. Immunology, 49, 95–102.Google Scholar
  25. 25.
    Harita, S., Shimokawa, Y. and Hayashi, H. (1983). Production of two lymphocyte chemotactic factors by antigen-stimulated guinea pig lymphocytes. Int. Arch. Allergy Appl. Immunol., 70, 118–123.Google Scholar
  26. 26.
    Harita, S., Shimokawa, Y., Mibu, Y., Ishida, M. and Hayashi, H. (1984). Lymphocyte chemotaxis in inflammation. IX. Further characterization of lymphocyte chemotactic lymphokines produced by purified protein derivative-stimulation in vitro and in vivo. Immunology, 51, 295–303.Google Scholar
  27. 27.
    Wilkinson, P.C., Roberts, J.A., Russell, R.J. and McLoughlin, M. (1976). Chemotaxis of mitogen-activated human lymphocytes and the effects of membrane-active enzymes. Clin. Exp. Immunol., 25, 280–287.Google Scholar
  28. 28.
    Hoffman, R.D., Klingerman, M., Sundt, T.M., Anderson, N.D. and Shin, H.S. (1982). Stereospecific chemoattraction of lymphoblastic cells by gradients of lysophosphatidylcholine. Proc. Natl. Acad. Sci., USA, 79, 3285–3289.CrossRefGoogle Scholar
  29. 29.
    Chenoweth, D.E., Goodman, M.G. and Weigle, W.O. (1982). Demonstration of a specific receptor for human C5a anaphylatoxin on murine macrophages. J. Exp. Med., 156, 68–78.Google Scholar
  30. 30.
    Parrott, D.M.V. (1980). Lymphocyte locomotion and migration. Prog. Allergy, 28, 193–284.Google Scholar
  31. 31.
    Center, D.M., Cruikshank, W.W., Berman, J.S. and Beer, D.J. (1983). Functional characteristics of histamine receptor-bearing mononuclear cells. I. Selective production of lymphocyte chemoattractant lymphokines with histamine used as a ligand. J. Immunol., 131, 1854–1859.Google Scholar
  32. 32.
    Center, D.M. (1983). Identification of rat mast cell-derived chemoattractant factors for lymphocytes. J. Allergy Clin. Immunol., 71, 29–35.Google Scholar
  33. 33.
    Rocklin, R.E., Breard, J., Gupta, S., Good, R.A. and Melmon, K.L. (1980). Characterization of the human blood lymphocytes that produce a histamine-induced suppressor factor (HSF). Cell Immunol., 51, 226–237.CrossRefGoogle Scholar
  34. 34.
    Rocklin, R.E. and Beer, D.J. (1983). Histamine and immune modulation. In Advances in Internal Medicine, Vol. 28, (ed. G.H. Stollerman), Year Book Medical Pub. Inc., Chicago, pp. 225–251.Google Scholar
  35. 35.
    Shimokawa, Y., Harita, S., Higuchi, Y. and Hayashi, H. (1982). Lymphocyte chemotaxis in inflammation. III. Demonstration of lymphocyte chemotactic activity in extract from PPD-induced delayed hypersensitivity skin reaction site in the guinea pig. Br. J. Exp. Path., 63, 355–361.Google Scholar
  36. 36.
    Shimokawa, Y., Harita, S., Higuchi, Y. and Hayashi, H. (1982). Lymphocyte chemotaxis in inflammation. IV. Isolation of lymphocyte chemotactic factors from PPD-induced delayed hypersensitivity skin reaction site in the guinea pig, with special reference to a factor chemotactic for B cells. Br. J. Exp. Path., 63, 362–368.Google Scholar
  37. 37.
    Shields, J.M. and Wilkinson, P.C. (1979). Relations between Fc receptor function and locomotion in human lymphocytes. Clin. Exp. Immunol., 38, 598–608.Google Scholar
  38. 38.
    Zigmond, S.H. and Hirsch, J.G. (1973). Leukocyte locomotion and chemotaxis: New methods for evaluation and demonstration of a cell-derived chemotactic factor. J. Exp. Med., 137, 387–410.Google Scholar
  39. 39.
    Shimokawa, Y., Harita, S. and Hayashi, H. (1979). Purification and functional specificity of lymphocyte chemotactic factors c and d from delayed hypersensitivity reaction sites. Proc. Jap. Soc. Immunol., 9, 337–338.Google Scholar
  40. 40.
    Shimokawa, Y., Harita, S. and Hayashi, H. (1981). Analysis of lymphocyte chemotactic lymphokines in delayed hypersensitivity skin reaction sites in guinea pig. Proc. Jap. Soc. Immunol., 11, 661–662.Google Scholar
  41. 41.
    Glazier, A.J., Monick, M. and Hunninghake, G.W. (1984). Chemotactic activity of interleukin 1 and interleukin 2 for blood monocytes and T cells. Clin. Res., 32, (abst), 347A.Google Scholar
  42. 42.
    Andrus, L., Granelli-Piperno, A. and Reich, E. (1984). Cytotoxic T cells both produce and respond to interleukin 2. J. Exp. Med., 59, 647–652.Google Scholar
  43. 43.
    Luger, T.A., Smolen, J.S., Chused, T.M., Steinberg, A.D. and Oppenheim, J.J. (1982). Human lymphocytes with either the OKT4 or OKT8 phenotype produce interleukin 2 in culture. J. Clin. Invest., 70, 470–473.CrossRefGoogle Scholar
  44. 44.
    Cantrell, D.A. and Smith, K.A. (1984). Expression and turnover of interleukin 2 receptors: Consequences for T-cell growth. Fed. Proc. 43, (abst.) 1607.Google Scholar
  45. 45.
    Sauder, D.N., Mounessa, N.L., Katz, S.I., Dinarello, C.A. and Gallin, J.I. (1984). Chemotactic cytokines: The role of leukocytic pyrogen and epidermal cell thymocyte-activating factor in neutrophil chemotaxis. J. Immunol., 132, 828–832.Google Scholar
  46. 46.
    Goodwin, J.S., Ceuppens, J.L. and Gualde, N. (184). Control of the immune response in humans by prostaglandins. In Therapeutic Control of Inflammatory Diseases — Advances in Inflammation Research, (eds. I. Otterness, R. Capetola and S. Wong), Raven Press, New York, pp. 79–92.Google Scholar
  47. 47.
    Chouaib, S. and Fradelizi, D. (1982). The mechanism of inhibition of human IL 2 production. J. Immunol., 129, 2463–2468.Google Scholar
  48. 48.
    Walker, C. Kristensen, F., Bettens, F. and DeWeck, A.L. (1983). Lymphokine regulation of activated (G,) lymphocytes. I. Prostaglandin E2-induced inhibition of interleukin 2 production. J. Immunol., 130; 1770–1773.Google Scholar
  49. 49.
    Chouaib, S., Chatenoud, L., Klatzmann, D. and Fradelizi, D. (1984). The mechanisms of inhibition of human IL 2 production. II. PGE2 induction of suppressor T lymphocytes. J. Immunol., 132, 1850–1857.Google Scholar
  50. 50.
    Kurland, J.I. and Bockman, R. (1978). Prostaglandin E production by human blood monocytes and mouse peritoneal macrophages. J. Exp. Med., 147, 952–957.Google Scholar
  51. 51.
    Rossier, J., French, E.D., Rivier, C. Ling, N., Guillemin, R. and Bloom, F.E. (1977). Foot-shock-induced stress increases beta-endorphin levels in blood but not brain. Nature, 270, 618–620.CrossRefGoogle Scholar
  52. 52.
    Wardlaw, S.L. and Frantz, A.G. (1980). Effects of swimming stress on brain beta-endorphins and ACTH. Clin. Res., 28 (abst.), 482a.Google Scholar
  53. 53.
    Genazzani, A.R., Facchinetti, F. and Parrini, D. (1981). Beta lipotropin and beta-endorphin plasma levels during pregnancy. Clin. Endocrinol., 14, 409–418.Google Scholar
  54. 54.
    Pvolakka, J., Kauppila, A., Leppaluoto, J. and Vuolteenaho, O. (1982). Elevated beta-en dorphin immunoreactivity in umbilical cord blood after complicated delivery. Acta. Obstet. Gynecol. Scand., 61, 513–514.Google Scholar
  55. 55.
    Fraiolo, F., Moretti, C. Paolucci, D., Aliccio, F., Cresenzi, F. and Fortunio, G. (1980). Physical exercise stimulates marked concomitant release of beta-endorphin and adrenocorticotropic hormone (ACTH) in peripheral blood in man. Experimentia, 36, 987–989.CrossRefGoogle Scholar
  56. 56.
    Nakao, K., Nakai, Y., Jingami, H., Oki, 5., Fukata, J. and Imura, H. (1979). Substantial rise of plasma beta-endorphin levels after insulin-induced hypoglycemia in human subjects. J. Clin. Endocrinol. Metab., 49, 838–841.Google Scholar
  57. 57.
    Johnson, H.M., Smith, E.M., Torres, B.A. and Blalock, J.E. (1982). Regulation of the in vitro antibody response by neuroendocrine hormones. Proc. Natl. Acad. Sci. USA, 79, 4171–4174.CrossRefGoogle Scholar
  58. 58.
    Mathew, P.M., Froelich, C.J., Sibitt, W.J. and Bankhurst, A.D. (1983). Enhancement of natural cytotoxicity by beta-endorphin. J. Immun., 130, 1658–1662.Google Scholar
  59. 59.
    Gilman, S.C., Schwartz, J.M., Milner, R.J., Bloom, F.E. and Feldman, J.D. (1982). Beta-endorphin enhances lymphocyte proliferative responses. Proc. Natl. Acad. Sci. USA, 79, 4226–4230.CrossRefGoogle Scholar
  60. 60.
    McCain, H.W., Lamster, I.B., Bozzone, J.M. and Grbic, J.T. (1982). Beta-endorphin modulates human immune activity via non-opiate receptor mechanisms. Life Sci., 31, 1619–1624.CrossRefGoogle Scholar
  61. 61.
    Simpkins, CO., Dickey, C.A. and Fink, M.P. (1984). Human neutrophil migration is enhanced by beta-endorphin. Life Sci., 34, 2251–2255.CrossRefGoogle Scholar
  62. 62.
    Hazum, E., Chang, K. and Cuatrecasas, P. (1979). Specific non-opiate receptors for beta-endorphin. Science, 205, 1033–1035.CrossRefGoogle Scholar
  63. 63.
    Chang, K.J. and Cuatrecasas, P. (1979). Multiple opiate receptors: Enkephalins and morphine bind to receptors of different specificity. J. Biol. Chem., 254, 2610–2618.Google Scholar
  64. 64.
    Gilbert, P.E. and Martin, W.R. (1976). The effects of morphine and nalorphine-like drugs in the nondependent, morphine-dependent and cyclazocine-dependent chronic spinal dog. J. Pharmacol. Exp. Ther., 198, 66–82.Google Scholar
  65. 65.
    Mehrishi, J.N. and Mills, I.H. (1983). Opiate receptors on lymphocytes and platelets in man. Clin. Immunol. Immunopathol., 27, 240–249.CrossRefGoogle Scholar
  66. 66.
    Lopker, A., Abgood, L.G., Hoss, W. and Lionetti, F.J. (1980). Stereospec if ic muscarinic, acetylcholine and opiate receptors in human phagocytic leukocytes. Biochem. Pharmacol., 29, 1361–1365.Google Scholar
  67. 67.
    Nash, A.A. and Gell, P.G.H. (1981). The delayed hypersensitivity T cell and its interaction with other T cells. Immunol. Today, 1, 162–165.Google Scholar
  68. 68.
    Bhan, A.K., Mihm, M.C. Jr. and Dvorak, H.F. (1982). T-cell subsets in allograft rejection. In situ characterization of T-cell subsets in human skin allografts by the use of monoclonal antibodies. J. Immunol., 129, 1578–1583.Google Scholar
  69. 69.
    McCluskey, R.T., Benacerraf, B. and McCluskey, J.W. (1963). Studies on the specificity of the cellular infiltrate in delayed hypersensitivity reactions. J. Immunol., 90, 466–477.Google Scholar
  70. 70.
    Miura, K., Shimokawa, Y., Honda, M. and Hayashi, H. (1983). Lyt phenotype of lymphocytes producing murine macrophage chemotactic lymphokine. Cell Immunol., 75, 383–389.Google Scholar
  71. 71.
    Laudenslager, M.L., Ryan, S.M., Drugan, R.C., Hyson, R.L. and Maier, S.F. (1983). Coping and immunosupression: Inescapable but not escapable shock suppresses lymphocyte proliferation. Science, 221, 568–570.CrossRefGoogle Scholar
  72. 72.
    Sklar, L.S. and Anisman, H. (1979). Stress and coping factors influence tumor growth. Science, 205, 513–515.CrossRefGoogle Scholar
  73. 73.
    Visintainer, M.A., Vollicelli, J.R, and Seligman, M.E.P. (1982). Tumor rejection in rats after inescapable or escapable shock. Science, 216, 437–439.CrossRefGoogle Scholar
  74. 74.
    Dorian, B., Garfinkel, P., Brown, G., Shore, A., Gladman, D. and Keystone, E. (1982). Aberrations in lymphocyte subpopulations and function during psychological stress. Clin. Exp. Immunol., 50, 132–138.Google Scholar
  75. 75.
    Pettingale, K.W., Greer, S. and Tee, D.E.H. (1977). Serum IGA and emotional expression in breast cancer patients. J. Psychosom. Res., 21, 395–399.Google Scholar
  76. 76.
    Bartrop, R.W., Lazarus, L., Luckhurst, E., Kilon, L.G. and Penny, R. (1977). Depressed lymphocyte function after bereavement. Lancet, i, 834–836.CrossRefGoogle Scholar
  77. 77.
    Pitkin, D.H. (1965). Effect of physiological stress on the delayed hypersensitivity reaction. Proc. Soc. Exp. Biol. Med., 120, 350–351.Google Scholar
  78. 78.
    Solomon, G.F. and Amkraut, A.A. (1981). Psychoneuro-endocrinological effects on the immune system. Ann. Rev. Microbiol., 35, 155–184.CrossRefGoogle Scholar
  79. 79.
    Hesse, D.G., Cole, D.J., Van Epps, D.E. and Williams, R.C. Jr. (1984). Decreased T-lymphocyte migration in patients with malignancy-mediated by a suppressor cell population. J. Clin. Invest., 73, 1078–1085.CrossRefGoogle Scholar
  80. 80.
    McFadden, R.G., Cruikshank, W.W. and Center, D.M. (1984). Modulation of lymphocyte migration by human lymphokines. III. Characterization of a lymphocyte migration inhibitory factor (LyMIF35k). Cell Immunol., 85, 154–167.CrossRefGoogle Scholar
  81. 81.
    Center, D.M., Austen, K.F. and Wintroub, B.U. (1978). Identification of chemoattractant activity for lymphocytes in bullous phemphigoid bullous fluid. Trans. Assoc. Am. Physicians, 91, 242–252.Google Scholar

Copyright information

© The Contributors 1985

Authors and Affiliations

  • D. E. Van Epps
  • J. Potter
  • S. L. Brown

There are no affiliations available

Personalised recommendations